We then investigated the hepatic expressions of TGFB1 and BAMBI in the experimental rat NASH model and, contrary to our expectations, did not find any effect of NPC2 treatment on the expression of either of these genes. This evidence concerns the gene NPC2 and metabolic dysfunction-associated steatohepatitis.